when was the first glp 1 agonist approved Timeline of GLP-1 discovery and clinical development. (a) Key events in Continued growth for GLP-1 receptor

Fasting leads to reduced microbiome-derived propionate production Short-chain fatty acids (SCFAs), which include propionate, are products of gut microbiome

Splenectomy : May be considered in cases of severe splenomegaly

Patient acceptability in terms of preferred treatment options as per real-world scenarios

I'm pretty sensitive to the effects of things so am sure I'd know pronto if there was a problem

Clinicians should monitor patients for potential adverse effects including pancreatitis (severe, persistent abdominal pain), gallbladder disease (right upper quadrant pain), diabetic retinopathy complications (especially with rapid glucose improvement), acute kidney injury with dehydration, and hypoglycemia when combined with insulin or sulfonylureas

D.ParkS.WalleniusV.LiuJ